1. No category

3rd European Conference
on the Biology of
Hydrogen Sulfide
H2S 2015
May 3–6 Athens, Greece
http://dx.doi.org/10.1016/j.niox.2015.02.144
PROGRAMME
Sunday, May 3
14:00–17:30
17:20–17:30
17:30–18:30
18:30–18:50
19:00–21:00
Registration
Welcome-Opening remarks
Opening Lecture
“The biology of H2S: what can we learn from the use H2S donors” OP1
P.K. Moore, Singapore
Science, Innovation and Translational Medicine: Winning for patients
B. Baroutsou, Greece
Welcome reception
Monday, May 4
Chemistry and Detection of H2S (Co-organized with Working Group 3 BM1005)
Chairs: H. Kimura (Japan), R. Banerjee (USA)
09:00–09:30
09:30–10:00
10:00–10:30
10:30–10:45
10:45–11:15
Chemical Biology of the H2S and NO crosstalk OP2
M. Filipovic, Germany
Mechanistic Chemical Perspective of Hydrogen Sulfide Signaling OP3
P. Nagy, Hungary
Chemical tools for imaging H2S in live organisms OP4
M. Pluth, USA
Novel lab-on-a-chip detection device for hydrogen sulfide in aqueous samples PP61
J.H. Chidlow Jr, USA
Coffee break
H2S Signalling (Co-organized with Working Group 1 BM1005)
Chairs: C. Szabo (USA), J. Wallace (Canada)
11:15–11:45
11:45–12:15
12:15–12:45
12:45–13:15
13:15–13:30
13:30–15:00
Role of Hydrogen Sulfide in Evolution and the Evolution of Hydrogen Sulfide Signaling OP5
K.R. Olson, USA
Hydrogen sulphide and polysulfides as signalling molecules OP6
H. Kimura, Japan
Thiol redox sensing and signalling OP7
P. Eaton, UK
Role of thiosulfate on hydrogen sulfide-mediated redox signaling in endothelial cells OP8
X. Shen, USA
Proteomic analysis of cysteine persulfides in H2S-dependent signalling PP27
S. Longen, Germany
Group photo and Lunch
COST Special Lecture (BM1005)
Chairs: A. Papapetropoulos (Greece), G. Cirino (Italy)
15:00–16:00
CBS Update: Structure, CBS Replacement Therapy, H2S Production OP9
J. Kraus, USA
Pharmacology of H2S (Co-organized with Working Group 4 BM1005)
Chairs: F. Bouillaud (France), M. Feelisch (UK)
16:00–16:30
17:45–19:15
Therapeutic potential of mitochondria-targeted hydrogen sulfide donors OP10
M. Whiteman, UK
All H2S donors are not created equal OP11
A. Papapetropoulos, Greece
Urogenital tract, phosphodiesterase -5 and the hydrogen sulfide pathway OP12
G. Cirino, Italy
Hydrogen sulfide donors: new potential agents in melanoma treatment PP74
A. Ianaro, Italy
Poster session
19:15
Sightseeing and Dinner
16:30–17:00
17:00–17:30
17:30–17:45
Tuesday, May 5
H2S and cardiovascular physiology/pathophysiology
Chairs: J. Bian (Singapore), J. Pfeilschifter (Germany)
09:00–09:30
Novel Hydrogen Sulfide Therapeutics for Cardiovascular Disease OP13
D.J. Lefer, USA
Tuesday, May 5
H2S and cardiovascular physiology/pathophysiology
09:30–10:00
10:00–10:30
10:30–10:45
10:45–11:00
11:00–11:15
11:15–11:45
Preeclampsia: An accelerator-brake defect disorder OP14
A. Ahmed, UK
Hydrogen sulfide and vascular oxidative stress OP15
J. Hart, Australia
Hydrogen Sulfide Therapy Attenuates the Development of Heart Failure by Increasing the Activity of the
Proteasome in a Nrf2-Dependent Manner PP30
J. Calvert, USA
Relaxant effects of H2S in human umbilical vessels PP72
E. Villamor, Netherlands
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2S availability PP53
L. Morbidelli, Italy
Coffee break
H2S metabolism and metabolic effects
Chairs: A. Ahmed (UK), M. Whiteman (UK)
11:45–12:15
12:15–12:45
12:45–13:15
13:15–13:30
13:30–13:45
13:45–14:00
14:00–15:15
Sulfide Oxidation and the Generation of Reactive Sulfur Species OP16
R. Banerjee, USA
Mitochondria and sulfide OP17
F. Bouillaud, France
Hydrogen sulfide maintains mitochondrial DNA replication via demethylation of TFAM OP18
G. Yang, Canada
Hydrogen sulfide in lung adenocarcinoma: a tumor cell survival factor, an enhancer of mitochondrial DNA repair
and a cellular bioenergetic stimulator PP81
B. Szczesny, USA
H2S-induced increase in hepatic glucose production and the underlying mechanisms PP33
A.A. Untereiner, Canada
Hydrogen sulfide stimulates adipose tissue lipolysis – an in vivo microdialysis study PP92
J. Bełtowski, Poland
Lunch
H2S in inflammation and ischemia
Chairs: J. Hart (Australia), K. Olson (USA)
15:15–15:45
17:00–19:00
Hydrogen Sulfide is a Cytoprotective, Rescue Molecule in the GI Tract OP19
J. Wallace, Canada
H2S and hypoxic brain damage OP20
F. Ichinose, USA
Hydrogen sulphide in renal disease and transplantation OP21
H. van Goor, Netherlands
Systemic infection and combined burn and infection: contribution of host-derived and bacterial-derived hydrogen
sulfide production to bacterial clearance PP82
T. Toliver-Kinsky, USA
Poster session
19:00
Dinner
15:45–16:15
16:15–16:45
16:45–17:00
Wednesday, May 6
Focus on cancer
Chairs: D. Lefer (USA), K. Ondrias (Slovakia)
09:00–10:00
Gasotransmitters in cancer OP22
C. Szabo, USA
H2S and the nervous system
Chairs: H. van Goor (Netherlands), F. Ichinose (USA)
10:00–10:30
10:30–11:00
Disrupted cysteine homeostasis leads to aberrant second messenger signaling and neurodegeneration in
Huntington’s disease OP23
P. Bindu, USA
Hydrogen sulfide inhibits amyloidogenesis and neuroinflammation via a STAT3/cathepsin S dependent pathway
OP24
J. Bian, Singapore
H2S and the nervous system
11:00–11:30
11:30–11:45
11:45–12:15
12:15
Hydrogen sulfide signaling and chronic visceral hypersensitivity OP25
Guang-Yin Xu, China
TRPA1 receptor-activating effect of hydrogen sulfide and polysulfides in sensory neurons PP93
E. Pintér, Hungary
JBC/Herbert Tabor Young Investigator award
Ciro Coletta award
British Microcircultion Society award
Concluding remarks
CONGRESS SECRETARIAT:
Imagine Congress & Travel
Kolokotroni str 9, 10562 Athens, Greece
Tel +30-210-3252520 Fax +30-210-3252530
Email: [email protected], [email protected]
Website: www.imaginecongress.gr
Congress website: www.H2S2015athens.org